is glp 1 the same as ozempic Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer's Trial Comparing Ozempic, Wegovy and Other

G., Chen, L., Chou, C

For example, in clinical trials of semaglutide 2.4 mg (Wegovy), nausea occurred in approximately 44% of patients, while rates for tirzepatide and other GLP-1s vary: Nausea : Often described as mild queasiness, particularly after eating, though some patients experience more pronounced nausea Bloating and abdominal fullness : A sensation of delayed digestion or food sitting heavily in the stomach Changes in bowel habits : Constipation affects approximately 15-30% of patients (varying by medication and dose), while some experience diarrhea or alternating patterns [1] [4] Decreased appetite : Beyond simple fullness, many report a fundamental shift in food thoughts, with reduced cravings and less mental preoccupation with eating Some patients report fatigue or low energy , particularly during the initial weeks

We further discussed body composition , protein intake , and the importance of maintaining muscle during weight loss

Many owners now test white label telehealth platforms as an alternative

Not all peptides fit every person the same way